ArticleTranslational cancer research2020

REBECA trial: a new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer.

Daniele Lavacchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.